![]() |
Quote:
|
Yes
The only administration in History to have a working Pharma Lab in the basement of the White House Between tweets, Don would often be found, in the lab, making doses of the tRump Vax No doses, 2 x and poof...cured Jonas Salk Don Trump Heros |
Quote:
That’s a pretty significant change in guidance and given the ridiculous logistics of shipping it at minus 94, something they should have looked at earlier. Did so,etching change or did they just not get around to it. Given the extreme logistics that were needed to keep it at those temps, I would have thought this would have been a priority. It is quite clear the second dose is a booster. My guess is what they are REALLY saying is that the first does is *good enough* that as a society it’s better to get more people one dose, than half of us two doses. Also an interesting question. ...or did something change? |
Jesus Christ zig, can't you keep politics out of anything? GTFOOH
There's no reason for this to end up in PARF but your jackassery is going to get it moved there. |
I came across this article this morning. I thought it was an interesting take.
https://www.msn.com/en-us/health/medical/a-johns-hopkins-professor-predicts-the-us-will-reach-herd-immunity-by-april-but-many-experts-arent-so-optimistic/ar-BB1dRhJZ?li=BBnb7Kz |
Quote:
|
Quote:
The road to success is paved with squirrels who weren’t concerned about what was coming. |
Quote:
..at this point I dont think anyone has the option of one vaccine vs. the others. It is my understanding that the two dose Phizer has had a higher effective rate against some of the variants and at this point would be my "choice" if I got one, but I'd like to understand more... |
Quote:
...but then it begs the question as to whether these folks developed an an immunity and how long it will last. Certainly not all will - maybe only a few. I've seen data that suggests an asymptomatic case may not bring immunity. |
Quote:
Nothing remotely conclusive. Heck...has there been data to confirm the immunity from the vaccine will last any longer? |
Quote:
|
The UK (Astro Zeneca) and now Pfizer have been back checking the data from the vaccine studies and is finding that a single dose is "good enough". Now we can double the number of people vaccinated with the same infrastructure. This is good news.
On the temperatures, Pfizer was being very cautious. And they have had a few months to work on the effectiveness with less severe refrigeration. And note, the "normal freezer" temps are only allowed for storage for two weeks. You have to keep it at -94F if you want to keep it stored for multiple months or transport. Pfizer I believe also has a shorter life in the bottle once warmed up to injection temps. Texas Center for Drug Development is running three vaccine studies in our area: Pfizer, Moderna and Novavax. I was there yesterday getting my second "real" Moderna injection. I chatted with one of the nurses and the Novavax study is done. They are compiling the data and will be doing the FDA submittal soon. Even after the submittal, we're still in the trial. They take blood and see how the antibodies develop and then track overtime the loss. I signed up for the Moderna Booster trial as well. We will see when that comes around. J&J is days away from approval. That will add a HUGE amount of vaccine to the USA and the world. J&J says they can supply a billion doses this year. Maybe not as effective as the new guys. But better to get good vaccines out than wait for the others to produce. |
Agree. I’m interested in the J&J iteration. Developed for single dose using a similar technology to other vaccines (HIV and tuberculosis). And...this being a multi-billion dollar business, one has to wonder about Pfizer’s motives to also become approved for single use with J&J’s drug on the horizon.
|
Quote:
https://www.fda.gov/news-events/press-announcements/fda-statement-following-authorized-dosing-schedules-covid-19-vaccines "Until vaccine manufacturers have data and science supporting a change, we continue to strongly recommend that health care providers follow the FDA-authorized dosing schedule for each COVID-19 vaccine." |
Interesting topic, not sure how many here work in healthcare. Both my wife and I work in healthcare, she in patient care in radiology me in sales radiology/surgery. I can back up the COVID numbers falling off a cliff at least locally to us. I think the public at large misunderstands FDA review/approval protocols which by and large unless you are really into that kind of stuff who cares.
It makes sense that both Pfizer and Moderna went ultra conservative in testing and what data was submitted for review, keep in mid both companies had a ton at stake with what in the business is called at risk manufacturing (doses ready to go into arms as soon as given the green light). You want that to go right or its untold millions down the tubes. The manufacture I sell equipment used in surgery and many others use at risk manufacturing, then as more data is compiled product refinements are made. These sometimes result in the need to resubmit data to FDA for approval sometimes not. This at risk manufacturing had a huge role in how quickly this vaccine was produced. |
Quote:
|
Quote:
To date, several adenovirus-based vaccines are in clinical and pre-clinical trials. Vaccines developed against HIV, Ebola virus, influenza virus, Mycobacterium tuberculosis, and Plasmodium falciparum are currently under human clinical trials. Moreover, there are vaccines under preclinical trials developed against rabies virus, dengue virus, and middle east respiratory syndrome coronavirus. |
Quote:
|
Quote:
|
Nothing about the statement is parf. You can use that as a concern though I can't?
|
All times are GMT -8. The time now is 03:26 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Search Engine Optimization by vBSEO 3.6.0
Copyright 2025 Pelican Parts, LLC - Posts may be archived for display on the Pelican Parts Website